MSRB3 and metastatic malignant neoplasm in the lymph nodes: (25) screened DACT3, TNS1, and MSRB3 using co-expression network analysis based on the WGCNA algorithm, which may provide novel therapeutic targets for BLCA patients with lymph node metastasis.